Overview

A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test whether treatment with Xevinapant added to standard chemoradiation after surgery is an effective treatment for people with high-risk head and neck cancers.

Phase:

PHASE2

Details

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Treatments:

Cisplatin